+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NATCOPHARM

Natco Pharma Share Price

₹903.15 -48.55 (-5.1%)
26.38% Fall from 52W High

14 Aug, 2026 3:59 PM (IST)

Natco Pharma live price: ₹903.15. It opened at ₹952 vs previous close ₹952; intraday high/low: ₹965/₹886. The 50 & 200 DMA stand at ₹944.10/₹956.80.

Natco Pharma Performance

  • Today's Low
  • ₹886
  • Today's High
  • ₹965
  • 52 Week Low
  • ₹789
  • 52 Week High
  • ₹1,227
  • Open Price₹952
  • Previous Close₹952
  • Volume2,668,954
  • 50 DMA₹944.10
  • 100 DMA₹958.00
  • 200 DMA₹956.80

Natco Pharma Chart

Investment Returns

  • Over 1 Month -7.11%
  • Over 3 Month -25.01%
  • Over 6 Month + 9.63%
  • Over 1 Year + 3.28%

Smart Investing Starts Here Start SIP with Natco Pharma for Steady Growth!

Invest Now

Natco Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.1
  • PEG Ratio
  • -0.4
  • Market Cap Cr
  • 16,176
  • P/B Ratio
  • 1.8
  • Average True Range
  • 28.5
  • EPS
  • 63.9
  • Dividend Yield
  • 0.6
  • MACD Signal
  • -7.5
  • RSI
  • 42.72
  • MFI
  • 32.24

Latest Stock News Updates

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Weblink of Audio Transcript for the earnings call held on 14th August, 2026 for Q1FY2026-27

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation for the Q1FY27

Natco Pharma's Q1 net down 57% at 206 crore

Revenue stood at 794 crore marking a decline of 43% in the quarter under review as against 1,390 crore for the corresponding quarter last year.

Natco Pharma Financials

Natco Pharma Technicals

EMA & SMA

Current Price
₹903.15
-48.55 (-5.1%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹925.20
  • 50 Day
  • ₹944.10
  • 100 Day
  • ₹958.00
  • 200 Day
  • ₹956.80

Resistance and Support

918.12 Pivot Speed
  • R3 1,028.40
  • R2 996.60
  • R1 949.90
  • S1 871.40
  • S2 839.60
  • S3 792.90

Natco Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-14 Quarterly Results & Interim Dividend
2026-05-29 Audited Results
2026-03-24 Scheme of Arrangement Inter alia, to consider among other things, the Scheme of Arrangement for the demerger of Agrochemicals Division on a going concern basis into its WoS i.e., Natco Crop Health Sciences Limited.
2026-02-12 Quarterly Results & Interim Dividend
2025-11-14 Quarterly Results & Interim Dividend
Date Purpose Remarks
2026-02-18 INTERIM Rs.1.50 per share(75%)Third Interim Dividend
2025-11-20 INTERIM Rs.1.50 per share(75%)Second Interim Dividend
2025-08-19 INTERIM Rs.2.00 per share(100%)Interim Dividend
2025-02-18 INTERIM Rs.1.50 per share(75%)Third Interim Dividend
2024-11-27 INTERIM Rs.1.50 per share(75%)Second Interim Dividend (RD & XD dates revised)
View Natco Pharma Dividend History Arrow

Natco Pharma Shareholding Pattern

49.42%
27.97%
16.99%
3.71%
1.92%

About Natco Pharma

Natco Pharma Ltd. is leading pharmaceutical company in India, specializing in production of generic medicines, bulk drugs, & specialty pharmaceuticals. Founded in 1981, Natco has established itself as key player in global pharmaceutical industry, with strong focus on oncology, cardiology, & gastroenterology segments. company operates state of the art manufacturing facilities that comply with global regulatory standards, ensuring production of high quality medicines. Natco Pharma is known for its innovation, particularly in development of affordable generic versions of high cost drugs, which has made it preferred partner for healthcare providers worldwide.

NATCO Pharma Limited (NATCO) is pharmaceutical firm that focuses on research & development & is vertically integrated. Its core competencies include creating, producing, & selling complicated pharmaceuticals for specific therapeutic areas. NATCO is now present in three business categories of contract manufacturing business, active pharmaceutical ingredients (APIs), & final dosage formulations (FDF).
 

View More
  • NSE Symbol
  • NATCOPHARM
  • BSE Symbol
  • 524816
  • ISIN
  • INE987B01026

Similar Stocks to Natco Pharma

Natco Pharma FAQs

Natco Pharma share price is ₹903 As on 16 August, 2026 | 01:59

The Market Cap of Natco Pharma is ₹16176.3 Cr As on 16 August, 2026 | 01:59

The P/E ratio of Natco Pharma is 14.1 As on 16 August, 2026 | 01:59

The PB ratio of Natco Pharma is 1.8 As on 16 August, 2026 | 01:59

The 52 week High & Low of Natco Pharma is ₹1226.8/₹789 respectively As on 16 August, 2026 | 01:59

Evaluate company's performance in pharmaceutical industry & its product pipeline before investing
 

Key metrics include revenue growth, product approvals, & profit margins.

Open Demat account with 5 Paisa Capital & post doing KYC & active account search for Natco Pharma share, you can then put order as you prefer.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23